[1] Ito F,Cho CS,Rikkers LF,et al. Hilar cholangiocarcinoma:current management[J]. Ann Surg,2009,250(2):210.
[2] Otto G. Diagnostic and surgical approaches in hilar cholangio-carcinoma[J]. Int J Colorectal Dis,2007,22(2):101-108.
[3] 黄志强. 肝门部胆管癌外科治疗的现状与我见[J]. 中国实用外科杂志,2007,27(5):341-346.
[4] Miyazaki M,Kimura F,Shimizu H,et al. Recent advance in the treatment of hilar cholangio-carcinoma: hepatecto-mywith vascular resection[J]. J Hepatobiliary Pancreat Surg,2007,14(5):463.
[5] Hirano S,Kondo S,Tanaka E,et al. Outcome of surgical treatment of hilar cholangiocarcinoma:a special reference to postoperative morbidity and mortality[J]. J Hepatobiliary Pancreat Sci,2010,17(4):455-462.
[6] Nimura Y. Preoperative biliary drainage before resection forcholangiocarcinoma(Pro)[J]. HPB(Oxford),2008,10(2):130-133.
[7] Liu CL,Fan ST,Lo CM. et al Improved operative and survival outcomes of surgical treatment for hilar cholangiocarcinoma[J].Br J Surg 2006,93(12):1488-1494.
[8] Yoshida H,Mamada Y,Taniai N et al. One-step palliative treatment method for obstructive jaundice caused by unresectable malignancies by percutaneous transhepat ic insertion of an expandable metallic stent[J]. World J Gastro enterol,2006,12(15):2423.
[9] 刘志远,刘会春. 肝门部胆管癌诊治进展[J]. 中华全科医学杂志 2009,7(10):1114-1115.
[10] Fujiwara K,Armstrong D,Morgan M,et al Principles and practice of intraperitoneal chemotherapy for ovari-ancancer[J]. Int J Gynecol Cancer,2007,17(1):1-20.
[11] Hess LM,Alberts DS. The role of intraperitoneal therapy in advanced ovarian cancer [J]. Oncology,2007,21 (2):227-232.